Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioZen D adjunctive therapy in schizophrenia
IRCT20211118053100N1Phase 3Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cetirizine + cholecalciferol in schizophrenia, sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoints: Positive symptoms of schizophrenia, Negative symptoms of schizophrenia and 3 more. Started Dec 2021; status: completed.
02
Drugs
cetirizine + cholecalciferol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20211118053100N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211118053100N1.